These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8948311)
1. Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease. Gül A; Ozbek U; Oztürk C; Inanç M; Koniçe M; Ozçelik T Br J Rheumatol; 1996 Nov; 35(11):1178-80. PubMed ID: 8948311 [TBL] [Abstract][Full Text] [Related]
2. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease. Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675 [TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden mutation in patients with Behçet's disease. Oner AF; Gürgey A; Gürler A; Mesci L J Rheumatol; 1998 Mar; 25(3):496-8. PubMed ID: 9517770 [TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257 [TBL] [Abstract][Full Text] [Related]
5. Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behçet's disease. Ateş A; Düzgün N; Ulu A; Tiryaki AO; Akar N Pathophysiol Haemost Thromb; 2003; 33(3):157-63. PubMed ID: 15170396 [TBL] [Abstract][Full Text] [Related]
6. Association of factor V Leiden with Behçet's disease. Mammo L; Al-Dalaan A; Bahabri SS; Saour JN J Rheumatol; 1997 Nov; 24(11):2196-8. PubMed ID: 9375883 [TBL] [Abstract][Full Text] [Related]
7. A study on thrombophilic factors in Italian Behcet's patients. Caramaschi P; Poli G; Bonora A; Volpe A; Tinazzi I; Pieropan S; Bambara LM; Biasi D Joint Bone Spine; 2010 Jul; 77(4):330-4. PubMed ID: 20452800 [TBL] [Abstract][Full Text] [Related]
8. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445 [TBL] [Abstract][Full Text] [Related]
9. Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis. Chamorro AJ; Marcos M; Hernández-García I; Calvo A; Mejia JC; Cervera R; Espinosa G Autoimmun Rev; 2013 Mar; 12(5):607-16. PubMed ID: 23207285 [TBL] [Abstract][Full Text] [Related]
10. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events. Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831 [TBL] [Abstract][Full Text] [Related]
11. Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's disease. Lesprit P; Wechsler B; Piette JC; Du-Boutin LT; Godeau P; Alhenc-Gelas M; Aiach M Ann Rheum Dis; 1995 Oct; 54(10):860. PubMed ID: 7492231 [No Abstract] [Full Text] [Related]
12. Procoagulant mutations and venous thrombosis in Behçet's disease. Gül A; Aslantas AB; Tekinay T; Koniçe M; Ozçelik T Rheumatology (Oxford); 1999 Dec; 38(12):1298-9. PubMed ID: 10587567 [No Abstract] [Full Text] [Related]
13. Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutation. Vayá A; Forner MJ; Estellés A; Villa P; Mira Y; Ferrando F; García Fuster JM; Oliver V; Aznar J Haematologica; 2000 Apr; 85(4):425-8. PubMed ID: 10756370 [TBL] [Abstract][Full Text] [Related]
14. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation. Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846 [TBL] [Abstract][Full Text] [Related]
15. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Turkstra F; Karemaker R; Kuijer PM; Prins MH; Büller HR Thromb Haemost; 1999 Mar; 81(3):345-8. PubMed ID: 10102457 [TBL] [Abstract][Full Text] [Related]
16. The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individuals. Ko YL; Hsu TS; Wu SM; Ko YS; Chang CJ; Wang SM; Chen WJ; Cheng NJ; Kuo CT; Chiang CW; Lee YS Hum Genet; 1996 Aug; 98(2):176-7. PubMed ID: 8698336 [TBL] [Abstract][Full Text] [Related]
17. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484 [TBL] [Abstract][Full Text] [Related]
18. Vascular behcet and mutations in thrombogenic genes: methylene tetrahydrofolate reductase, factor V, and prothrombin. Dagan E; Baruch Y; Fiorilli M; Rozenbaum M; Rosner I; Gershoni-Baruch R Genet Test Mol Biomarkers; 2012 Jan; 16(1):30-5. PubMed ID: 21861708 [TBL] [Abstract][Full Text] [Related]